Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Gilead Sciences Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Pharmaconex
Not Confirmed
arrow
Pharmaconex
Not Confirmed

LEDIPASVIR, SOFOSBUVIR

Brand Name : HARVONI

Patent Number : 2682230

Filing Date : 2008-03-26

Strength per Unit : 90 mg / 400 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2028-03-26

Date Granted : 2014-04-22

blank

02

arrow
Pharmaconex
Not Confirmed
arrow
Pharmaconex
Not Confirmed

LEDIPASVIR, SOFOSBUVIR

Brand Name : HARVONI

Patent Number : 2761258

Filing Date : 2010-05-12

Strength per Unit : 90 mg / 400 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-05-12

Date Granted : 2015-08-04

blank

03

arrow
Pharmaconex
Not Confirmed
arrow
Pharmaconex
Not Confirmed

LEDIPASVIR, SOFOSBUVIR

Brand Name : HARVONI

Patent Number : 2794669

Filing Date : 2011-03-31

Strength per Unit : 90 mg / 400 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2031-03-31

Date Granted : 2016-10-11

blank

04

arrow
Pharmaconex
Not Confirmed
arrow
Pharmaconex
Not Confirmed

LEDIPASVIR, SOFOSBUVIR

Brand Name : HARVONI

Patent Number : 2852867

Filing Date : 2014-01-30

Strength per Unit : 90 mg / 400 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2034-01-30

Date Granted : 2016-12-06

blank

05

Gilead Sciences Canada Inc.

arrow
Pharmaconex
Not Confirmed

Gilead Sciences Canada Inc.

Country
arrow
Pharmaconex
Not Confirmed

LEDIPASVIR, SOFOSBUVIR

Brand Name : HARVONI

Patent Number : 2840242

Filing Date : 2012-09-14

Strength per Unit : 90 mg / 400 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2032-09-14

Date Granted : 2019-03-26

blank